Jacob Opio

Dr. Jacob Opio

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

9 December 2022 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
JOJacob Opio
Jacob Opio
Katie WynneKatie Wynne
Katie Wynne
JAJohn Attia
John Attia
SHStephen Hancock
Stephen Hancock
COChristopher Oldmeadow
Christopher Oldmeadow
Mark McEvoyMark McEvoy
Mark McEvoy

23 March 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
JOJacob Opio
Jacob Opio
Katie WynneKatie Wynne
Katie Wynne
JAJohn Attia
John Attia
COChristopher Oldmeadow
Christopher Oldmeadow
SHStephen Hancock
Stephen Hancock
Mark McEvoyMark McEvoy
Mark McEvoy
Background: The relationship between overweight or obesity and depressive symptoms in individuals with or without cardio-metabolic abnormalities is unclear. In a cross-sectional study we examined the odds of experiencing depressive symptoms in overweight or obese older adults with or without metabolic abnormalities. Methods: The participants included 3318 older adults from the Hunter Community Study Cohort with a Body Mass Index (BMI) ≥ 18.5 kgm2, stratified by BMI and metabolic health risk. Obesity was defined as BMI ≥ 30 kgm2 and metabolically healthy as the absence of metabolic risk factors, according to International Diabetic Federation criteria for metabolic syndromes. Moderate to severe depressive symptoms were defined as a Centre for Epidemiological Studies Depression Scale (CES-D) score ≥ 16. Results: Compared to the metabolically healthy normal weight (MHNW) group, the odds of experiencing moderate/severe depressive symptoms were higher in those classified as a metabolically unhealthy normal weight (MUNW) (odds ratio (OR) = 1.25, 95% Confidence Interval (CI): 0.76–2.06) or metabolically unhealthy obesity (MUO) (OR = 1.48, 95% CI: 1.00–2.19), but not in those classified as metabolically unhealthy overweight (MUOW) (OR = 0.96, 95% CI: 0.63–1.45), metabolically healthy overweight (MHOW) (OR = 0.80, 95% CI: 0.51–1.26), and metabolically healthy obesity (MHO) (OR = 1.03, 95% CI: 0.65–1.64). Compared with MHNW males, the odds of moderate/severe depressive symptoms were increased in all other BMI category–metabolic health groups for males and females. Limitations: Our relatively small sample size and cross-sectional design did not allow us to robustly establish causality. Conclusion: The odds of experiencing moderate/severe depressive symptoms were increased in metabolically unhealthy older adults regardless of normal weight or obesity, with the odds of having moderate/severe depressive symptoms being higher in females than in males.

10 December 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
JOJacob Opio
Jacob Opio
Katie WynneKatie Wynne
Katie Wynne
JAJohn Attia
John Attia
SHStephen Hancock
Stephen Hancock
Mark McEvoyMark McEvoy
Mark McEvoy
Background: Few studies have explored the links between adiposity, metabolic health, and lung function. This study examined the cross-sectional association between spirometric lung function and overweight/obesity, with and without metabolic abnormalities, in older adults. Methods: The research involved 3,318 older adults from the Hunter Community Study Cohort who had a BMI of 18.5 kg/m2 or higher. Participants were grouped based on BMI and metabolic health risk. Obesity was defined as a BMI of 30 kg/m2 or more, while metabolic health was determined by the absence of risk factors according to the International Diabetes Federation criteria. Lung function was assessed via spirometry, measuring FEV1, FVC, predicted FEV1, predicted FVC, and FEV1/FVC ratio. Lung dysfunction was classified into restrictive, obstructive, mixed patterns, and deviations from predicted FEV1 and FVC. Results: The mean lung function measurements were as follows: FEV1 2.4 L (0.7), FVC 2.9 L (0.8), predicted FEV1% 88.7% (17.6), predicted FVC% 85.6% (15.7), and FEV1/FVC 82.5% (8.5). Compared to the metabolically healthy normal weight (MHNW) group, the odds of lung dysfunction were as follows. For the restrictive pattern, the MHOW group had an odds ratio (OR) of 1.00 (95% CI: 0.70–1.47, p = 0.959) and the MHO group had an OR of 1.67 (95% CI: 1.13–2.49, p = 0.011). For the obstructive pattern, the MHOW group had an OR of 0.39 (95% CI: 0.20–0.77, p = 0.007) and the MHO group had an OR of 0.36 (95% CI: 0.12–1.05, p = 0.061). For the mixed pattern, the MHOW group had an OR of 0.39 (95% CI: 0.18–0.87, p = 0.021) and the MHO group had an OR of 0.29 (95% CI: 0.10–0.87, p = 0.027). Conclusions: A higher BMI and variations in metabolic health are associated with an increased likelihood of restrictive lung function patterns. Conversely, obesity is inversely related to obstructive lung function patterns.